TY - JOUR
T1 - Identification of the PGRMC1 protein complex as the putative sigma-2 receptor binding site
AU - Xu, Jinbin
AU - Zeng, Chenbo
AU - Chu, Wenhua
AU - Pan, Fenghui
AU - Rothfuss, Justin M.
AU - Zhang, Fanjie
AU - Tu, Zhude
AU - Zhou, Dong
AU - Zeng, Dexing
AU - Vangveravong, Suwanna
AU - Johnston, Fabian
AU - Spitzer, Dirk
AU - Chang, Katherine C.
AU - Hotchkiss, Richard S.
AU - Hawkins, William G.
AU - Wheeler, Kenneth T.
AU - MacH, Robert H.
N1 - Funding Information:
This study was supported by CA 102869, American Cancer Society MRSG 08-019-01CDD, VA Merit Award 1136919 and by the McDonnell Center for Systems Neuroscience at Washington University. We thank Dr Leslie M. Hicks, Ms Jeanne Speichinger and Ms Rebecca White for help with the matrix-assisted laser desorption/ ionization–mass spectrometry analysis and protein sequencing.
PY - 2011
Y1 - 2011
N2 - The sigma-2 receptor, whose gene remains to be cloned, has been validated as a biomarker for tumour cell proliferation. Here we report the use of a novel photoaffinity probe, WC-21, to identify the sigma-2 receptor-binding site. WC-21, a sigma-2 ligand containing both a photoactive azide moiety and a fluorescein isothiocyanate group, irreversibly labels sigma-2 receptors in rat liver; the membrane-bound protein was identified as PGRMC1 (progesterone receptor membrane component 1). Immunocytochemistry reveals that both PGRMC1 and SW120, a fluorescent sigma-2 receptor ligand, colocalize with molecular markers of the endoplasmic reticulum and mitochondria in HeLa cells. Overexpression and knockdown of the PGRMC1 protein results in an increase and a decrease in binding of a sigma-2 selective radioligand, respectively. The identification of the putative sigma-2 receptor-binding site as PGRMC1 should stimulate the development of unique imaging agents and cancer therapeutics that target the sigma-2 receptor/PGRMC1 complex.
AB - The sigma-2 receptor, whose gene remains to be cloned, has been validated as a biomarker for tumour cell proliferation. Here we report the use of a novel photoaffinity probe, WC-21, to identify the sigma-2 receptor-binding site. WC-21, a sigma-2 ligand containing both a photoactive azide moiety and a fluorescein isothiocyanate group, irreversibly labels sigma-2 receptors in rat liver; the membrane-bound protein was identified as PGRMC1 (progesterone receptor membrane component 1). Immunocytochemistry reveals that both PGRMC1 and SW120, a fluorescent sigma-2 receptor ligand, colocalize with molecular markers of the endoplasmic reticulum and mitochondria in HeLa cells. Overexpression and knockdown of the PGRMC1 protein results in an increase and a decrease in binding of a sigma-2 selective radioligand, respectively. The identification of the putative sigma-2 receptor-binding site as PGRMC1 should stimulate the development of unique imaging agents and cancer therapeutics that target the sigma-2 receptor/PGRMC1 complex.
UR - http://www.scopus.com/inward/record.url?scp=79960099287&partnerID=8YFLogxK
U2 - 10.1038/ncomms1386
DO - 10.1038/ncomms1386
M3 - Article
C2 - 21730960
AN - SCOPUS:79960099287
SN - 2041-1723
VL - 2
JO - Nature communications
JF - Nature communications
IS - 1
M1 - 380
ER -